Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T17:16:08.989Z.
Consensus retrieved: 2026-10-06T10:33:03.777Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T17:16:08.989Z.
Quote observation: 2026-10-06T17:13:08.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 07daf27a5d98c2e6040b1a84eec716383e035dd1d7ed5c9da608703ba97b77ea
Forward PE Ratio (N/A) = Dated Quote Price ($3.25) / Consensus Forward EPS ($-2.15)
FORWARD PE RATIO
N/A
CervoMed Inc.
Market Cap
$30.09M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| CervoMed Inc. (CRVO) | $30.09M | N/A |
| GridAI Technologies Corp. (GRDX)vs › | $29.95M | N/A |
| BeyondSpring Inc. (BYSI)vs › | $30.34M | N/A |
| Context Therapeutics Inc. (CNTX)vs › | $29.50M | N/A |
| MDxHealth S.A. (MDXH)vs › | $30.59M | N/A |
| Quantum Cyber N.V. (QUCY)vs › | $29.37M | N/A |
| OneMedNet Corporation (ONMD)vs › | $29.33M | N/A |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $31.12M | N/A |
| SCYNEXIS, Inc. (SCYX)vs › | $31.37M | N/A |
| Nortech Systems Incorporated (NSYS)vs › | $31.44M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $3.25, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-2.15 | $-2.69 – $-1.27 | 5 | n/m |
| 2027-12-31 | $-1.48 | $-1.79 – $-0.91 | 4 | n/m |
| 2028-12-31 | $-1.10 | $-1.56 – $-0.83 | 3 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
